accusol 35 potassium 4 mmol/l haemofiltration solution for intravenous injection
aa-med pty ltd - calcium chloride dihydrate, quantity: 1.286 g; magnesium chloride hexahydrate, quantity: 0.51 g; sodium chloride, quantity: 28.2 g; glucose monohydrate, quantity: 5.512 g (equivalent: glucose, qty 4.987 g); potassium chloride, quantity: 1.492 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.
accusol 35 potassium 2 mmol/l haemofiltration solution for intravenous injection
aa-med pty ltd - magnesium chloride hexahydrate, quantity: 0.51 g; calcium chloride dihydrate, quantity: 1.286 g; sodium chloride, quantity: 28.2 g; glucose monohydrate, quantity: 5.512 g (equivalent: glucose, qty 4.987 g); potassium chloride, quantity: 0.746 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.
dbl® sodium phosphate and potassium phosphate concentrated injection
hospira nz ltd - dibasic sodium phosphate dodecahydrate 0.192 g/ml; monobasic potassium phosphate 0.0174 g/ml - solution for injection - active: dibasic sodium phosphate dodecahydrate 0.192 g/ml monobasic potassium phosphate 0.0174 g/ml excipient: water for injection
dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate tablet
avera mckennan hospital - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg
dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate tablet
kaiser foundation hospitals - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg
dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate tablet
cardinal health - sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic, anhydrous 852 mg
diacol sodium phosphate 1.5g tablet bottle
fresenius kabi australia pty ltd - dibasic sodium phosphate,monobasic sodium phosphate monohydrate -
dbl sodium phosphate and potassium phosphate concentrated injection
hospira australia pty ltd - potassium phosphate - monobasic; sodium phosphate - dibasic dodecahydrate -
dbl potassium phosphate - monobasic 0.54g and potassium phosphate - dibasic
hospira australia pty ltd - potassium phosphate - dibasic; potassium phosphate - monobasic -
phoxilium™ 1.2 mmol/l, phosphate
vantive limited - calcium chloride dihydrate 3.68 g/l; ; magnesium chloride hexahydrate 2.44 g/l; ; dibasic sodium phosphate dihydrate 0.225 g/l; ; potassium chloride 0.314 g/l; sodium bicarbonate 2.92 g/l; sodium chloride 6.44 g/l; - dialysis solution - active: calcium chloride dihydrate 3.68 g/l magnesium chloride hexahydrate 2.44 g/l excipient: hydrochloric acid water for injection active: dibasic sodium phosphate dihydrate 0.225 g/l potassium chloride 0.314 g/l sodium bicarbonate 2.92 g/l sodium chloride 6.44 g/l excipient: carbon dioxide water for injection - · used for crrt (continuous renal replacement therapy) in critically ill patients with arf (acute renal failure) when ph and kalaemia have been restored to normal and when the patients need phosphate supplementation for loss of phosphate in the ultrafiltrate or to the dialysate during crrt. · may also be used in case of drug poisoning or intoxications when the poisons are dialysable or pass through the membrane. · for use in patients with normal kalaemia and normal or hypophosphataemia